HKU Scholars Hub: Browsing DSpace

Browsing by Author Berliba, E

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 6 of 6

	Title	Author(s)	Issue Date
	AB-729, a GalNAc-siRNA, results in robust reductions of HBV DNA and HBsAg in subjects with chronic hepatitis B infection Proceeding/Conference:Hepatology International	Sevinsky, H Gane, ED Gane, E Berliba, E Kim, YJ Holmes, J Lim, Y-S Strasser, S Sukeepaisarnjaroen, W Schwabe, C Jucov, A Lee, ACH Thi, EP Harasym, T Pamulapati, GR Wattamwar, P Kunta, J Sofia, M Sevinsky, H Gray, K Eley, T Picchio, G Sims, KD Yuen, RMF	2021
	Long-term suppression maintained after cessation of AB-729 treatment and comparable on-treatment response observed in HBeAg+ subjects. Poster Presentation (SAT443) Proceeding/Conference:The International Liver Congress 2022, 22-26 June 2022. Journal of Hepatology	Yuen, RMF Berliba, E Sukeepaisarnjaroen, W Holmes, J Leerapun, A Tangkijvanich, P Strasser, S Jucov, A Gane, EJ Thi, EP Sevinsky, N Medvedeva, E Sharma, V Gray, K Antoniello, D Picchio, G Sims, K Eley, T	2022
	Repeat dosing of the GalNAc-siRNA AB-729 in subjects with chronic hepatitis B results in robust and sustained HBsAg suppression Proceeding/Conference:Journal of Hepatology	Yuen, RMF Berliba, E Sukeepaisarnjaroen, W Strasser, S Tangkijvanich, P Holmes, J Leerapun, A Jucov, A Thi, EP Wattamwar, T Sofia, MJ Sevinsky, H Gray, K Antoniello, D Eley, T Picchio, G Sims, K Gane, E	2021
	Safety and pharmacodynamics of the GALNAC-siRNA AB-729 in subjects with chronic hepatitis B infection Proceeding/Conference:Hepatology	Yuen, RMF Berliba, E Kim, YJ Holmes, JA Lim, YS Strasser, SI Schwabe, C Jucov, A Lee, ACH Thi, EP Harasym, T Pamulapati, GR Wattamwar, P Kunta, J Sofia, MJ Sevinsky, H Gray, K Eley, T Picchio, GR Sims, K Gane, EJ	2020
	Safety, pharmacokinetics, and antiviral activity of the capsid inhibitor AB-506 from Phase 1 studies in healthy subjects and those with hepatitis B Journal:Hepatology Communications	Yuen, MF Berliba, E Sukeepaisarnjaroen, W Ahn, SH Tanwandee, T Lim, YS Kim, YJ Poovorawan, K Tangkijvanich, P Schwabe, C Eley, T Brown, J Lee, ACH Thi, EP Paratala, B Mani, N Sofia, MJ Picchio, G Sims, KD Gane, EJ	4-Oct-2022
	Safety, tolerability, pharmacokinetics (PK), and antiviral activity of the capsid inhibitor (CI) AB-506 in healthy subjects (HS) and chronic hepatitis B (CHB) subjects Proceeding/Conference:Hepatology	Yuen, RMF Berliba, E Sukeepaisarnjaroen, W Ahn, SH Tanwandee, T Lim, Y-S Kim, YJ Poovorawan, K Tangkijvanich, P Chan, HLY Eley, T Brown, J Moore, C Lee, ACH Kim, J Thi, EP Mani, N Rijnbrand, R Cole, A Sofia, MJ Picchio, GR Sims, K Gane, EJ	2019

Showing results 1 to 6 of 6